Production and molecular characterization of clinical phase I anti-melanoma mouse igG3 monoclonal antibody R24

Biotechnology Progress

Volumn 17, Issue 5, 2001, Pages 809-821

  Kemminer, S E ^a   Conradt, H S ^a   Nimtz, M ^a   Sagi D ^a   Peter Katalinic J ^a   Diekmann, O ^a   Drmic I ^a   Muthing J ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR CHARACTERIZATION;

ANALYTICAL PROCEDURES AND TECHNIQUES; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; BIOMEDICAL ENGINEERING; GANGLIOSIDE; GLYCOSYLATION; HYBRIDOMA CELL CULTURE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; MOUSE; PHENOTYPE; REPEATED BATCH FERMENTATION; SIALIC ACID; THIN LAYER CHROMATOGRAPHY; WESTERN BLOTTING;

BIOREACTORS; CARBOHYDRATES; CELLS; CHROMATOGRAPHY; METABOLISM; MONOCLONAL ANTIBODIES; PROTEINS;

BIOTECHNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC AGENTS; BIOREACTORS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; EPITOPES; GLYCOSYLATION; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0034793767     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp010068y     Document Type: Article

References (85)

1. Influence of cell- and media-derived factors on the integrity of a human monoclonal antibody after secretion into serum-free cell culture supernatants
2. Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma
3. Optimization of serum-free fermentation processes for antibody production
4. Off-line analysis in animal cell culture, methods
5. Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: Applications to antibody characterization
6. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma
7. D3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity
8. Expression of human interleukin-2 in recombinant baby hamster kidney, Ltk-, and Chinese hamster ovary cells. Structure of O-linked carbohydrate chains and their location within the polypeptide
9. An overview of cancer immunotherapy
10. Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies
11. Treatment of patients with malignant melanoma by monoclonal ganglioside antibodies
12. Immunorecognition of ganglioside epitopes: Correlation between affinity and cytotoxicity of gangliosides antibodies
13. Immunological responses to intrathecal and systemic treatment with ganglioside antibody R-24 in patients with malignant melanoma
14. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates
15. Isolation and structural characterization of glycosphingolipids of in vitro propagated bovine aortic endothelial cells
16. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells
17. Glycosidase activities in Chinese hamster ovary cell lysate and cell culture supernatant
18. Glycosidase activities of the 293 and NS0 cell-lines, and of an antibody-producing hybridoma cell-line
19. Removal of sialic acid from a glycoprotein in CHO cell culture supernatant by action of an extracellular CHO cell sialidase
20. Monoclonal antibody therapy for solid tumors
21. Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids
22. Structural characterization of glycoprotein carbohydrate chains by using digoxigenin-labeled lectins on blots
23. 2 incubator
24. Monoclonal anti-melanoma antibodies and their possible clinical use
25. Improved silver staining procedure for fast staining in PhastSystem development unit I. Staining of sodium dodecyl sulfate gels
26. Molecular characterization of β-trace protein in human serum and urine: A potential diagnostic marker for renal disease
27. Sialylated carbohydrate chains of recombinant human glycoproteins expressed in Chinese hamster ovary cells contain traces of N-glycolylneuraminic acid
28. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma
29. Nomenclature of lipids
30. Getting the glycosylation right: Implications for the biotechnology industry
31. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system
32. Analysis of therapeutic and immunogenic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma
33. Continuous cultures of fused cells secreting antibody of predefined specificity
34. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A
37. Gangliosides: Structure, isolation and analysis
38. Estimation of cell damage in bench- and pilot-scale affinity expanded-bed chromatography for the purification of monoclonal antibodies
39. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II
40. Effect of culture conditions on IgM antibody structure, pharmacokinetics and activity
41. Pairing of oligosaccharides in the Fc region of immunoglobulin G
42. Nano-electrospray ionization quadrupole time-of-flight tandem mass spectrometric analysis of a ganglioside mixture from human granulocytes
43. Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-α and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma
44. Structures of the sugar chains of mouse immunoglobulin G
45. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice
46. Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod
47. Different binding capacities of influenza A and Sendai viruses to gangliosides from human granulocytes
48. Improved separation of isomeric gangliosides by anion-exchange high-performance liquid chromatography
49. High-resolution thin-layer chromatography of gangliosides
50. Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes
51. TLC in structure and recognition studies of glycosphingolipids
52. High-performance liquid chromatography of glycosphingolipids
53. Sialidase activity in culture fluid of Chinese hamster ovary cells during batch culture and its effect on recombinant human antithrombin III integrity
54. Production of recombinant human antithrombin III on 20-L bioreactor scale: Correlation of supernatant neuraminidase activity, desialylation, and decrease of biological activity of recombinant glycoprotein
55. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside
56. Clear background and high sensitive protein staining with Coomassie Blue dyes in polyacrylamide gels: A systematic analysis
57. Rheumatoid factor avidity in patients with rheumatoid arthritis: Identification of pathogenic RFs which correlate with disease parameters and with the Gal(0) glycoform of IgG
58. Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms
59. Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells
60. Biological significance of carbohydrate chains on monoclonal antibodies
61. Advances in cancer immunotherapy
62. A general approach to desalting oligosaccharides released from glycoproteins
63. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation of total serum IgG
64. Immunoassays
65. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody
66. Parameters of growth and analysis of growth data
67. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate
68. D3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody
69. Agalactosyl glycoforms of IgG autoantibodies are pathogenic
70. Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics
71. Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas
72. Diversification of the IgG molecule by oligosaccharides
73. Biosynthesis and biology of N-glycolylneuraminic acid
74. Male-specific modification of human CD52
75. Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma
76. The quantitative estimation of cerebrosides in nervous tissue
77. Chromatographic separation of human brain gangliosides
78. Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody
79. Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G
80. Structural study of the sugar moieties of monoclonal antibodies secreted by human-mouse hybridoma
81. Gangliosides of human, cat, and rabbit spinal cords and cord myelin
82. D3 ganglioside in patients with melanoma: Induction of inflammatory responses at tumor sites
83. The use of lactate-dehydrogenase (LDH) release kinetics for the evaluation of death and growth of mammalian cells in perfusion reactors
84. Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells
85. Effect of glycosylation on antibody function: Implications for genetic engineering